William Renthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Trigeminal Ganglion | 3 | 2024 | 187 | 1.850 |
Why?
|
Nucleus Accumbens | 13 | 2023 | 358 | 1.630 |
Why?
|
Ganglia, Spinal | 2 | 2024 | 520 | 1.370 |
Why?
|
Migraine Disorders | 6 | 2022 | 1631 | 1.330 |
Why?
|
Methyl-CpG-Binding Protein 2 | 4 | 2023 | 187 | 0.960 |
Why?
|
Peripheral Nervous System | 3 | 2022 | 148 | 0.850 |
Why?
|
Rett Syndrome | 3 | 2023 | 165 | 0.800 |
Why?
|
Sensory Receptor Cells | 3 | 2024 | 496 | 0.730 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 30 | 0.730 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 53 | 0.710 |
Why?
|
Cocaine | 11 | 2013 | 982 | 0.610 |
Why?
|
Neuralgia | 2 | 2023 | 574 | 0.600 |
Why?
|
Proto-Oncogene Proteins c-fos | 9 | 2010 | 570 | 0.590 |
Why?
|
Epigenomics | 1 | 2023 | 910 | 0.580 |
Why?
|
Gene Expression Regulation | 12 | 2020 | 11842 | 0.570 |
Why?
|
Chromatin | 9 | 2023 | 2896 | 0.550 |
Why?
|
Epigenesis, Genetic | 8 | 2017 | 3655 | 0.540 |
Why?
|
Internal Capsule | 1 | 2016 | 137 | 0.500 |
Why?
|
Nociceptors | 3 | 2024 | 449 | 0.500 |
Why?
|
Wernicke Encephalopathy | 1 | 2014 | 27 | 0.470 |
Why?
|
Thiamine Deficiency | 1 | 2014 | 47 | 0.450 |
Why?
|
Central Nervous System | 1 | 2019 | 1329 | 0.410 |
Why?
|
Neuroma | 2 | 2024 | 110 | 0.410 |
Why?
|
Dopamine Uptake Inhibitors | 7 | 2013 | 298 | 0.380 |
Why?
|
Cocaine-Related Disorders | 4 | 2013 | 453 | 0.360 |
Why?
|
Thalamus | 1 | 2016 | 1010 | 0.350 |
Why?
|
Gene Expression Profiling | 9 | 2024 | 9313 | 0.350 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1377 | 0.340 |
Why?
|
RNA | 2 | 2019 | 2692 | 0.320 |
Why?
|
Histone Deacetylases | 5 | 2009 | 706 | 0.310 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2014 | 687 | 0.310 |
Why?
|
Substance-Related Disorders | 4 | 2009 | 4294 | 0.310 |
Why?
|
Brain | 12 | 2023 | 26597 | 0.310 |
Why?
|
Nervous System Diseases | 1 | 2018 | 1611 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17435 | 0.290 |
Why?
|
Histones | 9 | 2010 | 2552 | 0.290 |
Why?
|
Amphetamine | 1 | 2008 | 224 | 0.290 |
Why?
|
Mice | 29 | 2024 | 80065 | 0.280 |
Why?
|
Sequence Analysis, RNA | 3 | 2019 | 1983 | 0.280 |
Why?
|
Neuronal Plasticity | 5 | 2020 | 1420 | 0.280 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1639 | 0.280 |
Why?
|
Sirtuins | 1 | 2009 | 317 | 0.270 |
Why?
|
Pain | 2 | 2024 | 4980 | 0.270 |
Why?
|
Neurons | 14 | 2023 | 9287 | 0.250 |
Why?
|
Anorexia Nervosa | 1 | 2014 | 1370 | 0.240 |
Why?
|
Animals | 38 | 2024 | 166308 | 0.240 |
Why?
|
Behavior, Animal | 9 | 2010 | 1843 | 0.240 |
Why?
|
Genomics | 1 | 2020 | 5697 | 0.240 |
Why?
|
Reward | 6 | 2013 | 932 | 0.220 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2288 | 0.220 |
Why?
|
Genetic Variation | 1 | 2018 | 6456 | 0.220 |
Why?
|
Atlases as Topic | 1 | 2024 | 239 | 0.210 |
Why?
|
Meninges | 1 | 2024 | 194 | 0.200 |
Why?
|
DNA Methylation | 6 | 2019 | 4259 | 0.200 |
Why?
|
Phantom Limb | 1 | 2023 | 94 | 0.200 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9103 | 0.200 |
Why?
|
Stress, Psychological | 6 | 2010 | 4287 | 0.200 |
Why?
|
Axotomy | 1 | 2020 | 71 | 0.180 |
Why?
|
Analgesics, Opioid | 2 | 2016 | 3669 | 0.180 |
Why?
|
Spinal Nerves | 1 | 2020 | 86 | 0.180 |
Why?
|
Species Specificity | 1 | 2024 | 2411 | 0.170 |
Why?
|
Demyelinating Diseases | 1 | 2022 | 340 | 0.170 |
Why?
|
Dendritic Spines | 3 | 2010 | 243 | 0.170 |
Why?
|
Specimen Handling | 1 | 2024 | 694 | 0.170 |
Why?
|
Analgesia | 1 | 2023 | 448 | 0.160 |
Why?
|
Rats | 10 | 2024 | 23681 | 0.160 |
Why?
|
Mechanoreceptors | 1 | 2020 | 189 | 0.160 |
Why?
|
Mice, Inbred C57BL | 18 | 2024 | 21529 | 0.160 |
Why?
|
Acetylation | 4 | 2009 | 1046 | 0.150 |
Why?
|
Chromatin Assembly and Disassembly | 3 | 2008 | 628 | 0.150 |
Why?
|
Depression | 8 | 2010 | 7826 | 0.150 |
Why?
|
Headache | 2 | 2022 | 1223 | 0.150 |
Why?
|
Disease Models, Animal | 9 | 2024 | 17831 | 0.150 |
Why?
|
Sciatic Nerve | 1 | 2020 | 607 | 0.140 |
Why?
|
Neuroglia | 1 | 2022 | 938 | 0.140 |
Why?
|
Cornea | 1 | 2024 | 1336 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 4 | 2007 | 594 | 0.130 |
Why?
|
Placebos | 1 | 2020 | 1658 | 0.130 |
Why?
|
Hypesthesia | 1 | 2016 | 107 | 0.130 |
Why?
|
Constipation | 1 | 2020 | 549 | 0.130 |
Why?
|
Mosaicism | 1 | 2018 | 459 | 0.130 |
Why?
|
Humans | 28 | 2024 | 746070 | 0.120 |
Why?
|
Nerve Regeneration | 1 | 2020 | 781 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2019 | 2964 | 0.120 |
Why?
|
Imipramine | 3 | 2009 | 96 | 0.120 |
Why?
|
Pain Measurement | 1 | 2024 | 3437 | 0.120 |
Why?
|
Nervous System | 2 | 2008 | 540 | 0.110 |
Why?
|
Morphine Dependence | 1 | 2013 | 27 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2009 | 1173 | 0.110 |
Why?
|
PC12 Cells | 3 | 2009 | 317 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9692 | 0.110 |
Why?
|
Muscle Weakness | 1 | 2016 | 409 | 0.110 |
Why?
|
Thiamine | 1 | 2014 | 161 | 0.110 |
Why?
|
Adaptation, Physiological | 3 | 2008 | 1283 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2013 | 3784 | 0.100 |
Why?
|
Social Behavior | 3 | 2010 | 1122 | 0.100 |
Why?
|
Sirtuin 1 | 1 | 2013 | 244 | 0.100 |
Why?
|
Axons | 1 | 2020 | 1663 | 0.100 |
Why?
|
Narcotics | 3 | 2013 | 336 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1782 | 0.100 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1808 | 0.090 |
Why?
|
Dopamine | 3 | 2007 | 1571 | 0.090 |
Why?
|
Brain Concussion | 1 | 2022 | 1338 | 0.090 |
Why?
|
Serum Response Factor | 1 | 2010 | 78 | 0.090 |
Why?
|
Transcription Factors | 3 | 2023 | 12040 | 0.090 |
Why?
|
H-2 Antigens | 1 | 2010 | 357 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2924 | 0.090 |
Why?
|
Morphine | 3 | 2013 | 649 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7570 | 0.090 |
Why?
|
Dominance-Subordination | 4 | 2010 | 26 | 0.080 |
Why?
|
Antidepressive Agents | 4 | 2010 | 2864 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5761 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 849 | 0.080 |
Why?
|
Myogenic Regulatory Factors | 1 | 2008 | 102 | 0.080 |
Why?
|
Veterans | 1 | 2022 | 2518 | 0.080 |
Why?
|
Conditioning, Operant | 2 | 2006 | 306 | 0.080 |
Why?
|
Histone Deacetylase 1 | 1 | 2008 | 132 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2008 | 4858 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6831 | 0.070 |
Why?
|
Signal Transduction | 5 | 2013 | 23115 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2009 | 774 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12202 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 429 | 0.070 |
Why?
|
Emotions | 2 | 2010 | 2671 | 0.070 |
Why?
|
Down-Regulation | 3 | 2010 | 2906 | 0.070 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 490 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 470 | 0.070 |
Why?
|
Motor Activity | 4 | 2010 | 2666 | 0.070 |
Why?
|
Social Environment | 1 | 2010 | 1008 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 675 | 0.060 |
Why?
|
Male | 24 | 2024 | 351098 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7116 | 0.060 |
Why?
|
Electrophysiology | 1 | 2008 | 1267 | 0.060 |
Why?
|
Mesencephalon | 1 | 2006 | 327 | 0.060 |
Why?
|
Rats, Long-Evans | 3 | 2010 | 371 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2008 | 965 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7935 | 0.060 |
Why?
|
Zymosan | 1 | 2024 | 127 | 0.060 |
Why?
|
Benzamides | 1 | 2009 | 1341 | 0.060 |
Why?
|
Enzyme Inhibitors | 3 | 2009 | 3695 | 0.060 |
Why?
|
Limbic System | 1 | 2006 | 415 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2010 | 12742 | 0.060 |
Why?
|
Molar | 1 | 2024 | 149 | 0.050 |
Why?
|
Resilience, Psychological | 1 | 2010 | 680 | 0.050 |
Why?
|
Dental Pulp | 1 | 2024 | 82 | 0.050 |
Why?
|
Receptors, Opioid | 1 | 2023 | 143 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2023 | 14212 | 0.050 |
Why?
|
Behavior, Addictive | 1 | 2008 | 451 | 0.050 |
Why?
|
Receptors, Opioid, mu | 1 | 2023 | 154 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4576 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2024 | 253 | 0.050 |
Why?
|
Protein Transport | 1 | 2008 | 1962 | 0.050 |
Why?
|
Neuroimmunomodulation | 1 | 2024 | 173 | 0.050 |
Why?
|
Macaca | 1 | 2023 | 407 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2008 | 1405 | 0.050 |
Why?
|
Methylation | 3 | 2010 | 1074 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2009 | 9441 | 0.050 |
Why?
|
Biology | 1 | 2023 | 289 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1952 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2002 | 342 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12839 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10327 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2462 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 5 | 2010 | 8125 | 0.040 |
Why?
|
Transgenes | 1 | 2023 | 999 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1541 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2005 | 1218 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15367 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4115 | 0.040 |
Why?
|
Neuropeptides | 1 | 2005 | 941 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2013 | 866 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4312 | 0.040 |
Why?
|
Synapses | 2 | 2023 | 1739 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2856 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2005 | 890 | 0.040 |
Why?
|
Self Administration | 2 | 2010 | 382 | 0.040 |
Why?
|
Documentation | 1 | 2024 | 875 | 0.040 |
Why?
|
Wakefulness | 1 | 2005 | 1240 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2841 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 29620 | 0.040 |
Why?
|
Neostriatum | 2 | 2008 | 247 | 0.040 |
Why?
|
Computational Biology | 1 | 2009 | 3490 | 0.030 |
Why?
|
Chronic Disease | 2 | 2010 | 9114 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2005 | 1157 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2010 | 874 | 0.030 |
Why?
|
Ventral Tegmental Area | 2 | 2007 | 134 | 0.030 |
Why?
|
Phosphorylation | 2 | 2023 | 8298 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2009 | 10719 | 0.030 |
Why?
|
Social Isolation | 2 | 2009 | 354 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2008 | 3954 | 0.030 |
Why?
|
Fluoxetine | 2 | 2009 | 738 | 0.030 |
Why?
|
Sirtuin 2 | 1 | 2013 | 93 | 0.030 |
Why?
|
Hippocampus | 1 | 2006 | 3685 | 0.030 |
Why?
|
Opioid-Related Disorders | 1 | 2008 | 2089 | 0.030 |
Why?
|
DNA Damage | 1 | 2002 | 2390 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2008 | 11037 | 0.030 |
Why?
|
Neutrophils | 1 | 2024 | 3706 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1752 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2002 | 3411 | 0.020 |
Why?
|
Blotting, Western | 2 | 2010 | 5048 | 0.020 |
Why?
|
Mice, Inbred AKR | 1 | 2010 | 104 | 0.020 |
Why?
|
Helplessness, Learned | 1 | 2010 | 28 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4392 | 0.020 |
Why?
|
Enzyme Repression | 1 | 2010 | 30 | 0.020 |
Why?
|
Aged | 3 | 2024 | 164222 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1649 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 248 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2009 | 6220 | 0.020 |
Why?
|
Female | 5 | 2024 | 382129 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2009 | 118 | 0.020 |
Why?
|
Histone Deacetylase 2 | 1 | 2009 | 72 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5648 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2010 | 904 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2009 | 147 | 0.020 |
Why?
|
Sucrose | 1 | 2009 | 156 | 0.020 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 17 | 0.020 |
Why?
|
United States | 1 | 2016 | 70368 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5746 | 0.020 |
Why?
|
Mental Disorders | 1 | 2007 | 6637 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2008 | 160 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 458 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2009 | 284 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2006 | 129 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 35781 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2009 | 484 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2283 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3578 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2810 | 0.020 |
Why?
|
Gene Expression | 2 | 2009 | 7579 | 0.020 |
Why?
|
Locus Coeruleus | 1 | 2008 | 218 | 0.020 |
Why?
|
Food Preferences | 1 | 2009 | 394 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 86212 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1688 | 0.020 |
Why?
|
DNA | 1 | 2019 | 7199 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1089 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2005 | 106 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 987 | 0.020 |
Why?
|
Hallucinogens | 1 | 2008 | 182 | 0.020 |
Why?
|
Butyrates | 1 | 2005 | 164 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 659 | 0.020 |
Why?
|
Cell Size | 1 | 2006 | 617 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2006 | 552 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10591 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2008 | 1456 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15539 | 0.010 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2002 | 66 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2009 | 18891 | 0.010 |
Why?
|
Narcolepsy | 1 | 2005 | 196 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12985 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 945 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1410 | 0.010 |
Why?
|
Models, Biological | 2 | 2009 | 9443 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2002 | 252 | 0.010 |
Why?
|
Ethanol | 1 | 2008 | 1316 | 0.010 |
Why?
|
S Phase | 1 | 2002 | 414 | 0.010 |
Why?
|
Sleep, REM | 1 | 2005 | 589 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 876 | 0.010 |
Why?
|
Aggression | 1 | 2006 | 739 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 1413 | 0.010 |
Why?
|
Time Factors | 3 | 2008 | 39589 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2005 | 1202 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1439 | 0.010 |
Why?
|
Environment | 1 | 2005 | 1111 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12448 | 0.010 |
Why?
|
Gene Silencing | 1 | 2005 | 1511 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13493 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2006 | 2403 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17674 | 0.010 |
Why?
|
Genome | 1 | 2005 | 1744 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4276 | 0.010 |
Why?
|
HeLa Cells | 1 | 2002 | 3078 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4401 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3785 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5378 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6138 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 214419 | 0.010 |
Why?
|
Adult | 2 | 2024 | 214969 | 0.010 |
Why?
|
Attention | 1 | 2005 | 2367 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 78293 | 0.010 |
Why?
|
DNA Repair | 1 | 2002 | 2017 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5759 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2793 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9425 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12775 | 0.010 |
Why?
|
Electroencephalography | 1 | 2005 | 6072 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29296 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9524 | 0.000 |
Why?
|